Could MDMA help treat bulimia? early trial begins
NCT ID NCT07542145
First seen Apr 24, 2026 · Last updated Jun 23, 2026 · Updated 10 times
Summary
This early-stage study tests whether MDMA-assisted therapy can help people with bulimia nervosa. Forty adults will be assigned to one of three groups: standard therapy, MDMA with general therapy, or MDMA with bulimia-specific therapy. The MDMA groups include three medicine sessions and several therapy sessions over 10 weeks, with a 6-month follow-up. The main goal is to see if binge eating episodes decrease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BULIMIA NERVOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Psychiatry, Eating and Weight Disorders Program
RECRUITINGNew York, New York, 10028, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MDMA (assisted psychotherapy)
What this could lead to
If successful, this could point toward a new treatment option for bulimia nervosa that combines therapy with MDMA to reduce binge eating.
What could go wrong
This is a very early Phase 1 trial with only 40 people, so results may not apply broadly. MDMA can cause side effects like anxiety or increased heart rate, and the therapy is intensive.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.